Trial of Levofloxacin as Prophylaxis After Allogeneic Stem Cell Transplantation (SCT)

• Status: Unknown status
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the efficacy of levofloxacin to prevent bacterial infections in the postneutropenic period in patients who have undergone allogeneic stem cell transplantation (SCT).

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Charite University, Berlin, Germany
• Treatments: Levofloxacin; Ofloxacin

Criteria

Inclusion Criteria:

• Allogeneic SCT

• Postneutropenic period

• Written consent

Exclusion Criteria:

• Fever

• Antibiotic therapy

• Neutropenia

• Refusal by the patient